The influence of antigenic variation an cytotoxic T lymphocyte responses in HIV-1 infection

Journal of Molecular Medicine

Volumn 76, Issue 10, 1998, Pages 699-708

  Price, David A ^a,b,c,f   Meier, Ute C ^f   Klenerman, Paul ^f   Purbhoo, Marco A ^f   Phillips, Rodney E ^f   Sewell, Andrew K ^d,e,f  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b University of Oxford ^*

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d UNIVERSITY OF UTAH   (United States)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Altered peptide ligand; Cytotoxic T lymphocyte; Human immunodeficiency virus 1

Indexed keywords

AMINO ACID; PEPTIDE;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ANTIGENIC VARIATION; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PERSISTENT INFECTION; REVIEW; T LYMPHOCYTE;

ANTIGENIC VARIATION; HIV ANTIGENS; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; PEPTIDES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0031659446     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090050270     Document Type: Review

References (91)

1. Ploegh H (1998) Viral strategies of immune evasion. Science 280:248-253
2. Oldstone MBA (1997) How viruses escape from cytotoxic T lymphocytes: molecular parameters and players. Virology 234:179-185
3. Holland J, Spindler K, Horodyski F, Grabau E, Nichol S, Vande-Pol S (1982) Rapid evolution of RNA genomes. Science 215:1577-1585
4. Roberts JD, Behenek K, Kunkel TA (1988) The accuracy of reverse transcriptase from HIV-I. Science 242:1171-1173
5. Hu W-S, Temin HM (1990) Retroviral recombination and reverse transcription. Science 250:1227-1233
6. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS, Shaw GM (1995) Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117-122
7. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M (1995) Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123-126
8. Goodenow M, Huet T, Saurin W, Kwok S, Sninsky J, Wain-Hobson S (1989) HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions. J AIDS 2:344-352
9. Wolinsky SM, Korber BTM, Neumann AU, Daniels M, Kunstman KJ, Whetsell AJ, Furtado MR, Cao Y, Ho DD, Safrit JT, Koup RA (1996) Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 272:537-542
10. Robert-Guroff M, Popovic M, Gartner S, Markham P, Gallo RC, Reitz MS (1990) Structure and expression of tat-, rev-and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages. J Virol 64:3391-3398
11. Townsend A, Bodmer H (1989) Antigen recognition by class I-restricled T lymphocytes. Annu Rev Immunol 7:601-624
12. Rammensee H-G, Friede T, Stevanovic S (1995) MHC ligands and peptide motifs: first listing. Immunogenetics 41:178-228
13. Madden DR (1995) The three-dimensional structure of peptide-MHC complexes. Annu Rev Immunol 13:587-622
14. Smith KJ, Reid SW, Harlos K, McMichael AJ, Stuart DI, Bell JI, Jones EY (1996) Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53. Immunity 4:215-228
15. Smith KJ, Reid SW, Stuart DI, McMichael AJ, Jones FY, Bell JI (1996) An altered position of the α2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501. Immunity 4:203-213
16. Reid SW, McAdam S, Smith KJ, Klenerman P, O'Callaghan CA, Harlos K, Jakobsen BK, McMichael AJ, Bell JI, Stuart DI, Jones EY (1996) Antagonist HIV-1 Gag peptides induce structural changes in HLA B8. J Exp Med 184:2279-2286
17. Garboczi DN, Ghosh P, Utz LJ, Fan QR, Biddison WE, Wiley DC (1996) Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384:134-141
18. Garcia KC, Degano M, Stanfield RL, Brunmark A, Jackson MR, Peterson PA, Teyton L, Wilson IA (1996) An αβ T cell receptor structure at 2.5A and its orientation in the TCR-MHC complex. Science 274:209-219
19. Norment AM, Salter RD, Parham P, Engelhard VH, Littman DR (1988) Cell-cell adhesion mediated by CD8 and MHC class I molecules. Nature 336:79-81
20. Garcia KC, Scott CA, Brunmark A, Carbone FR, Peterson PA, Wilson IA, Teyton L (1996) CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes. Nature 384: 577-581
21. Gao GF, Tormo J, Gerth UC, Wyer JR, McMichael AJ, Stuart DI, Bell JI, Jones EY, Jakobsen BK (1997) Crystal structure of the complex between human CD8αα and HLA-A2. Nature 387:630-634
22. Wange RL, Samelson LE (1996) Complex complexes: signaling at the TCR. Immunity 5:197-205
23. Weiss A, Littman DR (1994) Signal transduction by lymphocyte antigen receptors. Cell 76:263-274
24. Viola A, Lanzavecchia A (1996) T cell activation determined by T cell receptor number and tunable thresholds. Science 273:104-106
25. Valitutti S, Mueller S, Cella M, Padovan E, Lanzavecchia A (1995) Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 375:148-151
26. Christinck ER, Luscher MA, Barber BH, Williams DB (1991) Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis. Nature 352:67-70
27. Sykulev Y, Joo M, Vturina I, Tsomides TJ, Eisen HN (1996) Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity 4:565-571
28. Berke G (1995) The CTL's kiss of death. Cell 81:9-12
29. Kaegi D, Ledermann B, Buerki K, Seiler P, Odermatt B, Olsen KJ, Podack ER, Zinkernagel RM, Hengartner H (1994) Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31-37
30. Koenig S, Conley AJ, Brewah YA, Jones GM, Leath S, Boots LJ, Davey V, Pantaleo G, Demurest JF, Carter C, Wannebo C, Yannelli JR, Rosenberg SA, Lane HC (1995) Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. Nat Med 1:330-336
31. Price DA, Goulder PJR, Klenerman P, Sewell AK, Easterbrook PJ, Troop M, Bangham CRM, Phillips RE (1997) Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci USA 94:1890-1895
32. Del Val M, Schlicht H-J, Ruppert T, Reddehase MJ, Koszinowski UH (1991) Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighbouring residues in the protein. Cell 66:1145-1153
33. Bergmann CC, Tong L, Cua R, Sensintaffar J, Stohlman S (1994) Differential effects of flanking residues on presentation of epitopes from chimeric peptides. J Virol 68:5306-5310
34. Eisenlohr LC, Yewdell JW, Bennink JR (1992) Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes. J Exp Med 175:481-487
35. Ossendorp F, Eggers M, Neisig A, Ruppert T, Groettrup M, Sijts A, Mengede E, Kloetzel P-M, Neefjes J, Koszinowski U, Melief C (1996) A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. Immunity 5:115-124
36. Phillips RE, Rowland-Jones S, Nixon DF, Gotch FM, Edwards JP, Ogunlesi AO, Elvin JG, Rothbard JA, Bangham CRM, Rizza CR, McMichael AJ (1991) Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354:453-159
37. Couillin I, Culmann-Penciolelli B, Gomard E, Choppin J, Levy J-P. Guillet J-G, Saragosti S (1994) Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein. J Exp Med 180:1129-1134
38. Borrow P, Lewicki H, Wei X, Horwitz MS, Peffer N, Meyers H, Nelson JA, Gairin JE, Hahn BH, Oldstone MBA, Shaw GM (1997) Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med 3:205-211
39. Meier U-C, Klenerman P, Griffin P, James W, Koeppe B, Larder B, McMichael A, Phillips R (1995) Cytotoxic T lymphocyte lysis inhibited by viable HIV mutants. Science 270:1360-1362
40. Goulder PJR, Phillips RE, Colbert RA, McAdam S, Ogg G, Nowak MA, Giangrande P, Luzzi G, Morgan B, Edwards A, McMichael AJ, Rowland-Jones S (1997) Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med 3:212-217
41. McAdam S, Klenerman P, Tussey L, Rowland-Jones S, Lalloo D, Phillips R, Edwards A, Giangrande P, Leigh-Brown A, Gotch F, McMichael A (1995) Immunogenic HIV variant peptides that bind to HLA-B8 can fail to stimulate cytotoxic T lymphocyte responses. J Immunol 155:2729-2736
42. Klenerman P, Rowland-Jones S, McAdam S, Edwards J, Daenke S, Lalloo D, Koeppe B, Rosenberg W, Boyd D, Edwards A, Giangrande P, Phillips RE, McMichael AJ (1994) Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature 369:403-407
43. Bertoletti A, Sette A, Chisari FV, Penna A, Levrero M, De Carli M, Fiaccadori F, Ferrari C (1994) Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 369:407-410
44. Bertoletli A, Costanzo A, Chisari FV, Levrero M, Artini M, Sette A, Penna A, Giubeni T, Fiaccadori F, Ferrari C (1994) Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J Exp Med 180:933-943
45. Khanna R, Burrows SR, Silins SL, Moss DJ, Poulsen LM, Burrows JM (1996) Cytotoxic T-lymphocyte clones specific for an immunodominant epitope display discerning antagonistic response to naturally occurring Epstein-Barr virus variants. J Virol 70:7306-7311
46. Lalvani A, Hurt N, Aidoo M, Kibatala P, Tanner M, Hill AVS (1996) Cytotoxic T lymphocytes to Plasmodium falciparum epitopes in an area of intense and perennial transmission in Tanzania. Eur J Immunol 26:773-779
47. Niewiesk S, Daenke S, Parker CE, Taylor G, Weber J, Nightingale S, Bangham CRM (1995) Naturally occurring variants of human T-cell leukemia virus type 1 Tax protein impair its recognition by cytotoxic T lymphocytes and the transactivation function of Tax. J Virol 69:2649-2653
48. Weiner A, Erickson AL, Kansopon J, Crawford K, Muchmore E, Hughes AL, Houghton M, Walker CM (1995) Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc Natl Acad Sci USA 92:2755-2759
49. Pircher H, Moskophidis D, Rohrer U, Buerki K, Hengartner H, Zinkernagel RM (1990) Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature 346:629-633
50. Pewe L, Wu GF, Barnett EM, Castro RF, Perlman S (1996) Cytotoxic T cell-resistant variants are selected in a virus-induced demyelinating disease. Immunity 5:253-262
51. Nowak MA, May RM, Phillips RE, Rowland-Jones S, Lalloo DG, McAdam S, Klenerman P, Koeppe B, Sigmund K, Bangham CRM, McMichael AJ (1995) Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 375:606-611
52. Goulder PJR, Sewell AK, Lalloo DG, Price DA, Whelan JA, Evans J, Taylor GP, Luzzi G, Giangrande P, Phillips RE, McMichael AJ (1997) Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA)-identical siblings with HLA-A*0201 are influenced by epitope mutation. J Exp Med 185:1423-1433
53. Goulder P, Price D, Nowak M, Rowland-Jones S, Phillips R, McMichael A (1997) Co-evolution of human immunodeficiency virus and cytotoxic T-lymphocyte responses. Immunol Rev 159:17-29
54. Jameson SC, Carbone FR, Bevan MJ (1993) Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. J Exp Med 177:1541-1550
55. Sewell AK, Hurcourt GC, Goulder PJR, Price DA, Phillips RE (1997) Antagonism of cytotoxic T lymphocyte-mediated lysis by natural HIV-1 altered peptide ligands requires simultaneous presentation of agonist and antagonist peptides. Eur J Immunol 27:2323-2329
56. d-restricted cytotoxic T lymphocyte clones specific for a photoreactive peptide derivative. J Exp Med 185:629-640
57. Wagner L, Yang OO, Garcia-Zepeda EA, Ge Y, Kalams S, Walker BD, Pasternack MS, Luster AD (1998) β-chemokines are released from HIV-1 specific cytolytic T-cell granules completed to proteoglycans. Nature 391:908-911
58. Price DA, Sewell AK, Dong T, Tan R, Goulder PJR, Rowland-Jones SL, Phillips RE (1998) Antigen-specific release of β-chemokines by anti-HIV-1 cytotoxic T lymphocytes. Curr Biol 8:355-358
59. Alam SM, Travers PJ, Wung JL, Nasholds W, Redpath S, Jameson SC, Gascoigne NRJ (1996) T-cell-receptor affinity and thymocyte positive selection. Nature 381:616-620
60. Lyons DS, Lieberman SA, Hampl J, Boniface JJ, Chien Y, Berg LJ, Davis MM (1996) A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity 5:53-61
61. Preckel T, Grimm R, Martin S, Weltzien HU (1997) Altered hapten ligands antagonize trinitrophenyl-specific cytotoxic T cells and block internalization of hapten-specific receptors. J Exp Med 185:1803-1813
62. Purbhoo MA, Sewell AK, Klenerman P, Goulder PJR, Hilyard KL, Bell JI, Jakobsen BK, Phillips RE (1998) Copresentation of natural HIV-1 agonist and antagonist ligands fails to induce the T cell receptor signalling cascade. Proc Natl Acad Sci USA 95:4527-4532
63. Evavold BD, Allen PM (1991) Separation of IL-4 production from TH cell proliferation by an altered T cell receptor ligand. Science 252:1308-1310
64. Klenerman P, Meier U-C, Phillips RE, McMichael, AJ (1995) The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency-virus. Eur J Immunol 25:1927-1931
65. Klenerman P, Phillips R, McMichael A (1997) Cytotoxic T-cell antagonism in HIV-1. Semin Virol 7:31-39
66. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR (1994) T cell receptor antagonist peptides induce positive selection. Cell 76:17-27
67. Valitutti S, Mueller S, Dessing M, Lanzavecchia A (1996) Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J Exp Med 183: 1917-1921
68. Hollsherg P, Weber WEJ, Dangond F, Batra V, Sette A, Hafler D (1995) Differential activation of proliferation and cytotoxicity in human T-cell lymphotropic virus type 1 Tax-specific CD8 T cells by an altered peptide ligand. Proc Natl Acad Sci USA 92:4036-4040
69. + cytotoxic T lymphocyte clones. Eur J Immunol 25:3381-3387
70. Esser MT, Krishnamurthy B, Braciale VL (1996) Distinct T cell receptor signaling requirements for perform-or FasL-mediated cytotoxicity. J Exp Med 183:1697-1706
71. + T cells by a self-derived peptide. Nature 378:295-298
72. Brossart P, Bevan MJ (1996) Selective activation of Fas/Fas ligand-medialed cytotoxicity by a self peptide. J Exp Med 183:2449-2458
73. Sloan-Lancaster J, Evavold BD, Allen PM (1993) Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature 363:156-159
74. De Magistris MT, Alexander J, Coggeshall M, Altman A, Gaeta FCA, Grey HM, Sette A (1992) Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell 68:625-634
75. Allen PM, Zinkeragel RM (1994) Promethean viruses? Nature 369:355-356
76. Chen YZ, Matsushita S, Nishimura Y (1996) Response of a human T cell clone to a large panel of altered peptide ligands carrying single residue substitutions in an antigenic peptide. J Immunol 157:3783-3790
77. Janeway CA Jr (1992) The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation. Annu Rev Immunol 10:645-674
78. Hampl J, Chien YH, Davis MM (1997) CD4 augments the response of a T cell to agonist but not to antagonist ligands. Immunity 7:379-385
79. Reich Z, Boniface JJ, Lyons DS, Borochov N, Wachtel KJ, Davis MM (1997) Ligand-specific oligomerization of T-cell receptor molecules. Nature 387:617-620
80. Valitutti S, Lanzavecchia A (1997) Serial triggering of TCRs: a basis for the sensitivity and specificity of antigen recognition. Immunol Today 18:299-304
81. Lanzavecchia A (1997) Understanding the mechanisms of sustained signaling and T cell activation. J Exp Med 185: 1717-1719
82. Reis e Sousa C, Levine EH, Germain RN (1996) Partial signaling by CD8+ T cells in response to antagonist ligands. J Exp Med 184:149-157
83. Sloan-Lancaster J, Shaw AS, Rothbard JB, Allen PM (1994) Partial T cell signaling: altered phospho-ζ and lack of Zap70 recruitment in APL-induced T cell anergy. Cell 79:913-922
84. Madrenas J, Wange RL, Wang JL, Isakov N, Samelson LE, Germain RN (1995) ζ phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science 267: 515-518
85. van Oers NSC, Tao W, Watts JD, Johnson P, Aebersold R, Teh H-S (1993) Constitutive tyrosine phosphorylation of the T-cell receptor (TCR) ζ subunit: regulation of TCR-associated protein tyrosine kinase activity by TCR ζ. Mol Cell Biol 13:5771-5780
86. van Oers NS, Killeen N, Weiss A (1994) ZAP-70 is constitutively associated with tyrosine-phosphorylated TCR ζ in murine thymocytes and lymph node T cells. Immunity 1:675-685
87. Janeway CA (1995) Ligands for the T-cell receptor: hard times for avidity models. Immunol Today 16:223-225
88. McKeithan TW (1995) Kinetic proofreading in T-cell receptor signal transduction. Proc Natl Acad Sci USA 92:5042-5046
89. Rabinowitz JD, Beeson C, Lyons DS, Davis MM, McConnell HM (1996) Kinetic discrimination in T-cell activation. Proc Natl Acad Sci USA 93:1401-1405
90. Margulies DH (1996) An affinity for learning. Nature 381: 558-559
91. Klenerman P, Phillips RE, Rinaldo CR, Wahl LM, Ogg G, May RM, McMichael AJ, Nowak MA (1996) Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection. Proc Natl Acad Sci USA 93:15323-15328